COMMUNIQUÉS West-GlobeNewswire

Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
30/12/2025
Company’s Capital and Strategic Focus Now Exclusively Focused on IM8 IM8 FY 2026 Revenue Projected to Reach $180 - $200 Million CHARLOTTE, N.C., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE [...]
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
30/12/2025
Five-Year Financing with Favorable Terms that Significantly Reduce Interest Rate STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its [...]
Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors
30/12/2025
TUCSON, Ariz., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart [...]
InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
30/12/2025
DENVER, Dec. 30, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible [...]
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer
30/12/2025
GARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
30/12/2025
New note provides greater repayment flexibility and less dilution with elimination of mandatory amortization payments, increased conversion floor price to $0.35, and expanded mandatory ELOC payments from 33% to 50% [...]
InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum
30/12/2025
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), subsequent post-hoc [...]
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
30/12/2025
– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) – – XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine development-stage [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
30/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 30 December 2025 at 14:00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Verano Expands West Virginia Medical Cannabis Dispensary Footprint to Six Statewide Locations with the Opening of Zen Leaf Charleston
30/12/2025
Zen Leaf Charleston is Verano’s sixth dispensary in West Virginia, joining additional retail locations in Buckhannon, Clarksburg, Morgantown, Westover and Wheeling Situated in the state’s capital city, Zen Leaf [...]
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
30/12/2025
NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader Opening the first trading session of the New Year marks an excellent beginning to 2026 for NovaBridge [...]
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
30/12/2025
KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan [...]
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
30/12/2025
— NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 — — Savolitinib has the potential to become the first selective MET inhibitor in [...]
Best Zepbound Alternative for 2026? FDA Regulatory Timeline Reshapes Telehealth Tirzepatide Access as SkinnyRx Platform Lists Compounded Options
30/12/2025
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access pathways using SkinnyRx as a platform reference based on publicly available disclosures. [...]
Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
30/12/2025
Mesoblast has option to draw down up to US$125 million by June 30, 2026 New facility does not encumber any of Mesoblast's material assets or intellectual property NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Mesoblast [...]
Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways
30/12/2025
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access Shape Patient Choices as MEDVi Lists Compounded GLP-1 Programs Starting at $179 Newark, DE, [...]
IvesMD Opens New Beverly Hills Headquarters, Expands Team to Meet Growing Demand for Inclusive Aesthetic and Gender-Affirming Care
30/12/2025
Plastic Surgery Practice, IvesMD, launches its next chapter with award-winning space designed by Maria Park Design BEVERLY HILLS, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- IvesMD , founded by Dr. Graham Ives M.D. and [...]
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
29/12/2025
SAN RAMON, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will participate at the J.P. Morgan Healthcare Conference on Wednesday, January 14 [...]
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
29/12/2025
Nyxoah to Present at the 44 th Annual J.P. Morgan Healthcare Conference Mont-Saint-Guibert, Belgium – December 29, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), [...]

Pages